AKT1 and lung carcinoma: Studies have shown that ES may inactivate the Akt pathway in a time- and dose-dependent manner, significantly inhibiting the proliferation of human lung squamous carcinoma cells and enhancing the sensitivity of lung cancer cells to radiation [29, 30].